The Pharmacy and Poisons Board (PPB) of Kenya has issued a public alert announcing the voluntary recall of S-PRAZO (Esomeprazole Magnesium Delayed-Release Capsules 40mg), Batch No SPZ-302, manufactured by Laborate Pharmaceutical India Limited.
In the notice issued on August 20, the board explained that the recall follows complaints about packaging mix-ups, where some boxes contained both S-Prazo Capsules and Donystatin Tablets.
“The product batch is being recalled following a market complaint regarding mix-up of blister strips; some boxes were found to contain two different blister strips, i.e. S-Prazo Capsules and Donystatin Tablets, within the same outer carton,” said the PPB.
As a result of the packaging mix-up, the board has urged all healthcare professionals, pharmaceutical outlets, healthcare facilities, and the public to immediately cease distribution and return the affected products to their suppliers or nearest healthcare facilities.
“The Board advises all pharmaceutical outlets, healthcare facilities, healthcare professionals and members of the public to STOP further distribution, sale, issuing or use of the product batch and return the specified product batch to their nearest healthcare facility or respective suppliers.”
Additionally, the Pharmacy and Poisons Board reiterated their commitment to safeguarding public health and emphasized the importance of reporting any suspected substandard medicines or adverse reactions through their official communication channels.
“The Board remains committed to protecting the health of the public and encourages the public to promptly report any suspected cases of sub- standard medicines or adverse drug reactions,” said the Board.
